Skip to content

Clinical trials

Observational Sleep Apnea, Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Phase: Observational Country / region: China Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20141
20154
20161
20175
20181
20192
20202
20215
20222
20233
20246
202510
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15
Completed14
Unknown status12
Not yet recruiting3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University First Hospital7
Beijing Anzhen Hospital4
Nanjing Medical University3
Beijing Children's Hospital2
Beijing Tsinghua Chang Gung Hospital2
Chinese Pulmonary Vascular Disease Research Group2
Chinese University of Hong Kong2
Huai'an No.1 People's Hospital2
Second Affiliated Hospital of Wenzhou Medical University2
Academic Centre for Dentistry in Amsterdam1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive46
Sleep Apnea Syndromes7
Hypertension5
Sleep Apnea, Central4
Apnea3
Pulmonary Disease, Chronic Obstructive3
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Acute Coronary Syndrome1
Anxiety Disorders1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.